SCHEMBL4047792

SCHEMBL4047792

COC(C)NC(=O)c1ccccc1.OBO

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.48
ALDH1A1 P00352 6/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
HPGD P15428 2/20 0.47
RAB9A P51151 2/20 0.47
LMNA P02545 4/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
TSHR P16473 2/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
KDM4E B2RXH2 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
NPC1 O15118 2/20 0.44
MEN1 O00255 2/20 0.44
HTT P42858 2/20 0.44
KMT2A Q03164 2/20 0.44
SLC1A2 P43004 1/20 0.44
PRSS1 P07477 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31575774 0.95 ALDH1A1 (0.51) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL4046626 0.85 MLYCD (0.53) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL24998749 0.79 MLYCD (0.58) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL155518 0.79 MLYCD (0.58) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL29772431 0.79 MLYCD (0.58) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL8380943 0.78 GAA (0.53) GAAALDH1A1SMN1; SMN2HPGDRAB9A
Hydrochloric Acid SCHEMBL28544859 0.77 MLYCD (0.56) GAAALDH1A1SMN1; SMN2HPGDRAB9A
Hydrochloric Acid SCHEMBL7849680 0.77 MLYCD (0.56) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL7522945 0.77 MLYCD (0.56) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL29171758 0.77 ALDH1A1 (0.49) GAAALDH1A1SMN1; SMN2HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2020404-A1 Cyanomethyl substituted N-Acyl Tryptamines Bayer Schering Pharma Aktiengesellschaft (DE) 2009-02-04 EP disclosed